Postoperative treatment of differentiated thyroid carcinoma with intermediate recurrence risk.
10.3881/j.issn.1000-503X.2013.04.004
- Author:
Xue YANG
1
;
Yan-song LIN
Author Information
1. Department of Nuclear Medicine, PUMC Hospital, Beijing, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Iodine Radioisotopes;
therapeutic use;
Neoplasm Recurrence, Local;
prevention & control;
Postoperative Period;
Risk Adjustment;
Thyroid Neoplasms;
pathology;
therapy
- From:
Acta Academiae Medicinae Sinicae
2013;35(4):378-381
- CountryChina
- Language:Chinese
-
Abstract:
The three-level recurrence stratification of differentiated thyroid carcinoma (DTC) has attracted wide attention since its introduction in 2009 American Thyroid Association guidelines. Among these three levels, the postoperative treatment of DTC with intermediate recurrence risk is highly controversial. This article summarizes the relevant advances and controversies in this field.
